Nuyten Dimitry SA has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 7856 shares of Arcus Biosciences, Inc. ($RCUS) on December 15, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Nuyten Dimitry SA | Chief Medical Officer | F | Common Stock | 7856 | $16.08 | 87,518.0000 | 0 | 8.24% | 0.00% |
| Sept. 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Nuyten Dimitry SA | Chief Medical Officer | F | Common Stock | 5385 | $17.95 | 94,933.0000 | 0 | 5.37% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Nuyten Dimitry SA | Chief Medical Officer | A | Common Stock | 28000 | $0.00 | 99,195.0000 | 0 | 39.33% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Nuyten Dimitry SA | Chief Medical Officer | A | Stock Option (right to buy) | 113700 | $0.00 | 113,700.0000 | 0 | 9999.99% | 0.00% |